Discovery and evaluation of cytisine N-isoflavones as novel EGFR/HER2 dual inhibitors
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference50 articles.
1. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers;Roskoski;Pharmacol. Res.,2019
2. Cell signaling by receptor tyrosine kinases;Lemmon;Cell,2010
3. Untangling the ErbB signalling network;Yarden;Nat. Rev. Mol. Cell Biol.,2001
4. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Cancer,2005
5. Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development;Kamath;Med. Res. Rev.,2007
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10
2. Total Syntheses and Antibacterial Studies of Natural Isoflavones: Scandenone, Osajin, and 6,8-Diprenylgenistein;Molecules;2024-05-30
3. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight;Phytotherapy Research;2024-03-03
4. Quinolizidine Alkaloids and Isoflavones from the Herb of Thermopsis lupinoides and Their Antiviral, Antifungal, and Insecticidal Activities;Journal of Agricultural and Food Chemistry;2024-02-23
5. Cornulacin: a new isoflavone from Cornulaca monacantha and its isolation, structure elucidation and cytotoxicity through EGFR-mediated apoptosis;RSC Medicinal Chemistry;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3